JNJ logo

Johnson & Johnson (JNJ)

Profile

Full Name

Johnson & Johnson

Ticker

NYSE: JNJ

Exchange

NYSE

Sector

Healthcare

Industry

General Drug Manufacturers

Country

United States

IPO

January 2, 1943

Indexes

S&P 500,Dow Jones

Website

https://www.jnj.com

Employees

138100

Key Details

Price

$186.57(-0.21%)

Market Cap

$449.50B(Mega cap)

Last Dividend

$1.30

TTM Dividend Yield

2.72%

Annual Revenue

$88.82B(4.31% YoY)

Annual EPS

$5.79(4.63% YoY)

PE Ratio

18.01

Next earnings date

Jan 21, 2026

Next ex-dividend date

Nov 25, 2025

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $186.57
    JNJ price is $186.57

    30-Day Relative Volume

    0.58
    JNJ 30-day relative volume is 0.58

    Price Performance

    Price Most Recent Change

    -0.21%
    JNJ price was down -0.21% on Nov 7, 2025

    Price YTD Change

    +29.01%
    JNJ price is up +29.01% since January 1st

    Price 1-Year Change

    +19.04%
    JNJ price is up +19.04% year-on-year

    Price 3-Year Change

    +7.86%
    JNJ price is up +7.86% over the past 3 years

    Price Range

    Price All-Time High

    $194.48
    JNJ price is currently -4.07% below its historical high of $194.48

    Price 3-Year Low

    $140.68
    JNJ price is currently +32.62% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $449.50B
    JNJ market cap is $449.50 billion

    Market Cap 3-Year Change

    -0.61%
    JNJ market cap is down -0.61% over the past 3 years

    Market Cap All-Time High

    $489.47B
    JNJ market cap is currently -8.16% below its historical high of $489.47 billion

    Market Cap Sector Percentile

    99.92%
    JNJ market cap is higher than 99.92% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.07%
    JNJ shares outstanding is up +0.07% year-on-year

    Shares Outstanding 3-Year Change

    -7.85%
    JNJ shares outstanding is down -7.85% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.04
    JNJ beta is 0.04

    200-day SMA

    $165.77
    JNJ price is currently +12.54% above its 200-day simple moving average

    50-day SMA

    $184.29
    JNJ price is currently +1.24% above its 50-day simple moving average

    14-Day RSI

    47.29
    JNJ 14-day relative strength index is 47.29

    Volume

    0.58
    JNJ 30-day relative volume is 0.58

    ATR

    $2.71
    JNJ average true range is $2.71

    10-day Historical Volatility

    14.03%
    JNJ 10-day historical volatility is 14.03%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $1.30
    JNJ last dividend was $1.30 per share, with an ex-dividend date of August 26, 2025

    Next Dividend

    $1.30
    JNJ has announced a dividend of $1.30 per share, with an ex-dividend date set for November 25, 2025

    Dividend per share

    Dividend Per Share

    $4.91
    JNJ annual dividend per share is $4.91

    Dividend Per Share Sector Percentile

    90.36%
    JNJ annual dividend per share is higher than 90.36% of companies in Healthcare sector

    Dividend Per Share 1-Year Change

    +4.47%
    JNJ annual dividend per share is up +4.47% year-on-year

    Dividend Per Share 3-Year Change

    +17.18%
    JNJ annual dividend per share is up +17.18% over the past 3 years

    Dividend yield

    Dividend Yield

    2.63%
    JNJ annual dividend yield is 2.63%

    Dividend Yield Sector Percentile

    63.41%
    JNJ annual dividend yield is higher than 63.41% of companies in Healthcare sector

    Other

    Payout Ratio

    84.05%
    JNJ annual payout ratio is 84.05%

    Dividends Paid

    $11.82B
    JNJ annual dividends paid is $11.82 billion

    Free Cash Flow

    $19.84B
    JNJ annual free cash flow is $19.84 billion

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $88.82B
    JNJ annual revenue is $88.82 billion

    Revenue Analysts Estimate

    $93.75B
    JNJ annual revenue is currently -5.26% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +4.31%
    JNJ annual revenue is up +4.31% year-on-year

    Revenue Sector Percentile

    99.24%
    JNJ annual revenue is higher than 99.24% of companies in Healthcare sector

    EPS

    EPS

    $5.79
    JNJ annual earnings per share is $5.79

    EPS Analysts Estimate

    $10.86
    JNJ annual earnings per share is currently -46.71% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +4.63%
    JNJ annual earnings per share is up +4.63% year-on-year

    EPS Sector Percentile

    96.11%
    JNJ annual earnings per share is higher than 96.11% of companies in Healthcare sector

    Profit

    Gross Profit

    $60.96B
    JNJ annual gross profit is $60.96 billion

    Gross Margin

    68.63%
    JNJ annual gross profit margin is 68.63%

    Operating Profit

    $20.82B
    JNJ annual operating income is $20.82 billion

    Operating Margin

    -7.93%
    JNJ annual operating profit margin is -7.93%

    Net Income

    $14.07B
    JNJ annual net profit is $14.07 billion

    Net Margin

    15.84%
    JNJ annual net profit margin is 15.84%

    Expenses

    Total Expenses

    $74.75B
    JNJ annual total expenses is $74.75 billion

    Operating Expenses

    $40.13B
    JNJ annual total operating expenses is $40.13 billion

    Cost Of Goods Sold

    $27.86B
    JNJ annual cost of goods sold is $27.86 billion

    Selling, General & Administrative Expenses

    $0.00
    JNJ annual SG&A is $0.00

    Depreciation & Amortization

    $7.34B
    JNJ annual D&A is $7.34 billion

    Interest Expense

    $0.00
    JNJ annual interest expense is $0.00

    Income Tax

    $2.62B
    JNJ annual income tax is $2.62 billion

    EBIT & EBITDA

    EBIT

    $20.82B
    JNJ annual earnings before interest & taxes is $20.82 billion

    EBITDA

    $28.16B
    JNJ annual EBITDA is $28.16 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $180.10B
    JNJ annual total assets is $180.10 billion

    Non Current Assets

    $124.21B
    JNJ annual long term assets is $124.21 billion

    Current Assets

    $55.89B
    JNJ annual total current assets is $55.89 billion

    Cash and Cash Equivalents

    $24.52B
    JNJ annual cash & cash equivalents is $24.52 billion

    Accounts Receivable

    $14.84B
    JNJ annual accounts receivable is $14.84 billion

    Inventory

    $12.44B
    JNJ annual inventory is $12.44 billion

    Liabilities

    Total Liabilities

    $108.61B
    JNJ annual total liabilities is $108.61 billion

    Long Term Liabilities

    $26.44B
    JNJ annual total long term liabilities is $26.44 billion

    Current Liabilities

    $50.32B
    JNJ annual current liabilities is $50.32 billion

    Accounts Payable

    $10.31B
    JNJ annual accounts payable is $10.31 billion

    Debt

    Total Debt

    $37.83B
    JNJ annual total debt is $37.83 billion

    Total Debt 1-Year Change

    +24.32%
    JNJ annual total debt is up +24.32% year-on-year

    Long Term Debt

    $31.85B
    JNJ annual long term debt is $31.85 billion

    Short Term Debt

    $5.98B
    JNJ annual short term debt is $5.98 billion

    Equity & Capital

    Shareholders Equity

    $71.49B
    JNJ annual stockholders equity is $71.49 billion

    Book Value

    $71.49B
    JNJ annual book value is $71.49 billion

    Retained Earnings

    $155.79B
    JNJ annual retained earnings is $155.79 billion

    Working Capital

    $5.57B
    JNJ annual working capital is $5.57 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    $24.27B
    JNJ annual cash from operations is $24.27 billion

    Cash From Operations 1-Year Change

    +6.47%
    JNJ annual cash from operations is up +6.47% year-on-year

    Cash From Investing

    -$18.60B
    JNJ annual cash from investing is -$18.60 billion

    Cash From Investing 1-Year Change

    -2218.34%
    JNJ annual cash from investing is down -2218.34% year-on-year

    Cash From Financing

    -$3.13B
    JNJ annual cash from financing is -$3.13 billion

    Cash From Financing 1-Year Change

    +80.21%
    JNJ annual cash from financing is up +80.21% year-on-year

    CAPEX

    CAPEX

    $4.42B
    JNJ annual capital expenditures is $4.42 billion

    CAPEX 1-Year Change

    -2.62%
    JNJ annual capital expenditures is down -2.62% year-on-year

    Free Cash Flow

    Free Cash Flow

    $19.84B
    JNJ annual free cash flow is $19.84 billion

    Free Cash Flow 1-Year Change

    +8.74%
    JNJ annual free cash flow is up +8.74% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    68.63%
    JNJ annual gross profit margin is 68.63%

    Operating Margin

    -7.93%
    JNJ annual operating profit margin is -7.93%

    Net Margin

    15.84%
    JNJ annual net profit margin is 15.84%

    ROA & ROE

    ROA

    8.09%
    JNJ annual return on assets is 8.09%

    ROE

    20.06%
    JNJ annual return on equity is 20.06%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    18.01
    JNJ price to earnings ratio is 18.01

    PE Ratio Sector Percentile

    36.32%
    JNJ price to earnings ratio is higher than 36.32% of companies in Healthcare sector

    PB Ratio

    PB Ratio

    5.67
    JNJ price to book ratio is 5.67

    PB Ratio Sector Percentile

    80.15%
    JNJ price to book ratio is higher than 80.15% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    4.88
    JNJ price to sales ratio is 4.88

    PS Ratio Sector Percentile

    57.32%
    JNJ price to sales ratio is higher than 57.32% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $476.74B
    JNJ enterprise value is $476.74 billion

    Enterprise Value Sector Percentile

    99.91%
    JNJ enterprise value is higher than 99.91% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    15.30
    JNJ EV/EBITDA is 15.30

    EV/EBITDA Sector Percentile

    87.81%
    JNJ EV/EBITDA is higher than 87.81% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    1.11
    JNJ annual current ratio is 1.11

    Quick Ratio

    0.86
    JNJ annual quick ratio is 0.86

    Leverage

    Debt To Equity

    0.53
    JNJ annual debt to equity ratio is 0.53

    Interest Coverage Ratio

    -
    JNJ annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    6
    JNJ piotroski f-score is 6

    Altman Z-Score

    4.61
    JNJ altman z-score is 4.61

    Analyst ratings

    Recent major analysts updates

    Oct 22, 25 Freedom Capital Markets
    Hold
    Oct 15, 25 Stifel
    Hold
    Oct 15, 25 Raymond James
    Outperform
    Oct 15, 25 Morgan Stanley
    Equal-Weight
    Oct 15, 25 Citigroup
    Buy
    Oct 15, 25 B of A Securities
    Neutral
    Oct 14, 25 UBS
    Buy
    Oct 10, 25 Morgan Stanley
    Equal-Weight
    Oct 9, 25 Goldman Sachs
    Buy
    Oct 7, 25 Citigroup
    Buy

    Institutional Ownership

    Screeners with JNJ included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    Most recommended stocks
    Best performing stocks last 5 years
    Dow Jones companies
    S&P 500 companies
    Stocks below analysts price target
    S&P 500 companies dividend calendar
    • What is the ticker symbol for Johnson & Johnson?
    • Does Johnson & Johnson pay dividends?
    • What sector is Johnson & Johnson in?
    • What industry is Johnson & Johnson in?
    • What country is Johnson & Johnson based in?
    • When did Johnson & Johnson go public?
    • Is Johnson & Johnson in the S&P 500?
    • Is Johnson & Johnson in the NASDAQ 100?
    • Is Johnson & Johnson in the Dow Jones?
    • When was Johnson & Johnson's last earnings report?
    • When does Johnson & Johnson report earnings?

    What is the ticker symbol for Johnson & Johnson?

    The ticker symbol for Johnson & Johnson is NYSE:JNJ

    Does Johnson & Johnson pay dividends?

    Yes, Johnson & Johnson pays dividends. The last payment was $1.30, with an ex-dividend date on August 26, 2025

    What sector is Johnson & Johnson in?

    Johnson & Johnson is in the Healthcare sector

    What industry is Johnson & Johnson in?

    Johnson & Johnson is in the General Drug Manufacturers industry

    What country is Johnson & Johnson based in?

    Johnson & Johnson is headquartered in United States

    When did Johnson & Johnson go public?

    Johnson & Johnson's initial public offering (IPO) was on January 2, 1943

    Is Johnson & Johnson in the S&P 500?

    Yes, Johnson & Johnson is included in the S&P 500 index

    Is Johnson & Johnson in the NASDAQ 100?

    No, Johnson & Johnson is not included in the NASDAQ 100 index

    Is Johnson & Johnson in the Dow Jones?

    Yes, Johnson & Johnson is included in the Dow Jones index

    When was Johnson & Johnson's last earnings report?

    Johnson & Johnson's most recent earnings report was on October 14, 2025

    When does Johnson & Johnson report earnings?

    The next expected earnings date for Johnson & Johnson is January 21, 2026
    On this page